Congenital
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping (NCT07587242) | Avidity Biosciences, Inc. | 2026-08-01 |
| Etablishment of Follow-up System and End-Stage Heart Registration Platform for Pediatric Heart Failure (NCT06345521) | China National Center for Cardiovascular Diseases | 2022-01-01 |
Track Congenital automatically
Every clearance here is in the API, with alerts when new ones post.